Table 3.

Visual Analog Scale Scores of Lesion Progression in Test and Control Groups at Baseline and 3- and 6-mo Follow-up.

	Test Group (n = 31)		Control Group (n = 34)		Treatment Effect
	Score	Missing Subjects	Score	Missing Subjects	Differencea (95% CI)	P Value	Odds Ratio (95% CI)a,b	P Value
Baseline	73.9 (18.4)	0	61.8 (20.4)	0
3 mo	−0.7 (36.5)	2	24.3 (32.2)	4
6 mo	−13.3 (39.7)	1	12.8 (39.6)	2
Baseline vs.
3 mo	−74.5 (37.0)	2	−39.7 (36.4)	4	31.7 (14.3 to 49.1)	0.0006	6.8 (2.2 to 21.4)	0.001
6 mo	−88.0 (40.8)	1	−49.1 (43.8)	2	38.1 (14.9 to 61.3)	0.0018	8.0 (2.3 to 27.2)	0.001
3 and 6 moc	NA		NA		35.3 (17.0 to 53.6)	0.0003	7.9 (3.1 to 20.3)	<0.0001

Data for groups are mean (SD).

NA, not applicable.

^aAdjusted for baseline values of visual analog scale, age, sex, and plaque.

^bOdds ratios are for the control group with the test group as reference.

^cEstimates were additionally adjusted for time point.